⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT April 21, 2026

Rivaroxaban +pharma 2,5 mg Filmtabletten 2,5 mg (Filmtablette)

📷 Wikipedia: Rivaroxaban · Source
Rivaroxaban +pharma 2,5 mg Filmtabletten 2,5 mg (Filmtablette)
📷 Wikipedia: Rivaroxaban · Source
Rivaroxaban +pharma 2.5 mg film-coated tablets are delayed in production. Affected packs: 60-tablet boxes are unavailable since 21 April 2026 and expected back on 1 June 2026; 100- and 30-tablet boxes remain available.
⚠️
Shortage ongoing
RIVAROXABAN is currently in short supply in AT.
📈 Timeline
10 days active so far
May 18, 2026 May 27, 2026

What is this? Rivaroxaban is a blood-thinning medicine. It comes as small tablets.

What's happening? The 2.5 mg tablets in packs of 60 are hard to find. Other pack sizes are still available.

Does this affect me? If you take the 60-tablet pack, you may have trouble getting more.

What should I do? Ask your pharmacist or doctor for help finding another pack size or brand.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
RIVAROXABAN
Agency-published detail

ATC: B01AF01 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: +pharma Arzneimittel gmbh, Hafnerstraße 211, 8054 Graz, Österreich · Affected packs: 60 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-04-21, resupply 2026-06-01] · 100 Stück Schachtel, Blisterpackung [verfügbar] · 30 Stück Schachtel, Blisterpackung [verfügbar]

First published
April 21, 2026
Last refreshed by us
15 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

High AT 1 week ago

Xarelto 10 mg Filmtabletten 10 mg (Filmtablette)

Xarelto 10 mg film-coated tablets Parallel export is prohibited. Affected pack sizes: 5-tablet box available; 10-tablet box unavailable since 30 April 2026, restocking 24 May 2026; 30- and 100-tablet...
High AT 1 week ago

Xarelto 20 mg Filmtabletten 20 mg (Filmtablette)

Xarelto 20 mg film-coated tablets Reason: increased additional requirement Marketed by Bayer AG, 51368 Leverkusen, Germany Available pack sizes: - 100-tablet bottle - 14-tablet blister pack - 28-ta...
High AT 1 month ago

Xarelto 15 mg Filmtabletten 15 mg (Filmtablette)

Xarelto 15 mg film-coated tablets are unavailable in packs of 100 tablets in blister packs since March 26, 2026, with restocking expected on April 17, 2026. Packs of 14, 28, 42, and 100 tablets in bot...
High AT 2 months ago

Rivaroxaban 1A Pharma 2,5 mg - Filmtabletten 2,5 mg (Filmtablette)

Rivaroxaban 1A Pharma 2.5 mg film-coated tablets are a medication. The affected pack size is 30 tablets in a blister pack.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Rivaroxaban +pharma 2,5 mg Filmtabletten 2,5 mg (Filmtablette). Rivaroxaban +pharma 2.5 mg film-coated tablets are delayed in production. Affected packs: 60-tablet boxes are unavailable since 21 April 2026 and expected back on 1 June 2026; 100- and 30-tablet boxes remain available.
▸ When was this alert issued?
This alert was issued on April 21, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.